MPM adds $408M for its next big wave of biotech startups — and oncology still dominates the menu
MPM Capital has put the finishing touches to its 7th venture fund — BV2018 — now tidily totting up to about $408 million as the venture crew …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
